GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model (rodent laboratory experiment with no human data)
PubMed 18541917 · doi:10.1073/pnas.0711755105
What was done
Researchers investigated the direct effects of glial cell line-derived neurotrophic factor (GDNF) administered into the ventral tegmental area (VTA) on alcohol-drinking and relapse behaviors in rats. They tested operant self-administration of ethanol versus sucrose across various doses, assessed intake in rats with a history of high voluntary ethanol consumption, and tested site specificity by infusing GDNF into the adjacent substantia nigra. They also evaluated downstream intracellular mechanisms by testing MAPK pathway activation and using a MAPK pathway inhibitor, and measured GDNF's effect on reacquisition of ethanol self-administration after extinction.
What was found
The abstract reports no numerical values, statistical test metrics, or effect sizes. GDNF infusion into the VTA caused a rapid, dose-dependent decrease in operant ethanol self-administration without affecting sucrose self-administration, and reduced drinking in rats with high voluntary intake. Infusions into the substantia nigra had no effect on ethanol responses. Intra-VTA GDNF activated the MAPK signaling pathway, and pharmacologic inhibition of MAPK blocked GDNF's suppression of ethanol self-administration. In an extinction-reacquisition paradigm, intra-VTA GDNF blocked the reacquisition of ethanol self-administration.
Why it matters
These findings identify intra-VTA GDNF signaling via the MAPK pathway as a rapid, site-specific mechanism that selectively curbs alcohol intake and seeking, pointing to potential therapeutic targets within neurotrophic signaling pathways for alcohol use disorder.
Limits
The study was conducted entirely in rodent models, so direct applicability to human alcohol dependence is unproven. The abstract omits sample sizes, specific dosage regimens, quantitative effect magnitudes, and variance estimates. Potential long-term safety, durability of effect, and systemic delivery challenges for GDNF were not addressed in the abstract.
Cited by
- supports Injecting glial-derived neurotrophic factor (GDNF) directly into the ventral tegmental area of rodents causes them to stop self-administering alcohol.